Christopher Carlos, MD, MAS

HS Asst.Clinical Professor

Dr. Christopher Carlos is an Assistant Professor within the Division of Nephrology and a board-certified nephrologist. He practices both inpatient and outpatient nephrology. In his outpatient clinic, he specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders.

Dr. Carlos earned his medical degree from Case Western Reserve University School of Medicine. He completed his residency in Internal Medicine at UCSF, where he also completed a fellowship in Nephrology. During his fellowship, he obtained a Master's Degree in Clinical Research from the UCSF School of Epidemiology and Biostatistics. His primary research interest was in the effect of dialysis therapies on physical function and well-being.

He is a member of the American Society of Nephrology and National Kidney Foundation.

Education
MAS, 2019 - Clinical Research, UCSF
Fellowship, 2018 - Nephrology, UCSF
Residency, 2016 - Internal Medicine, UCSF
MD, 2013 - School of Medicine, Case Western Reserve University
BA, 2007 - Human Biology, Stanford University
Publications

  1. Ku E, Copeland TP, McCulloch CE, Seth D, Carlos CA, Cho K, Malkina A, Lo LJ, Hsu RK. Intensive Home Blood Pressure Lowering in Patients with Advanced CKD. American journal of kidney diseases : the official journal of the National Kidney Foundation 2024. PMID: 39427725


  2. Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE, ICPi-AKI Consortium Investigators. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. Journal for immunotherapy of cancer 2022. PMID: 36137651


  3. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney international 2022. PMID: 35964800


  4. Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE, ICPi-AKI Consortium. Acute kidney injury in patients treated with immune checkpoint inhibitors. 2021. PMID: 34625513


  5. Natsuhara KH, Zhang L, Carlos CA, Borno HT.. Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study 2021. PMID:


  6. Carlos C, Grimes B, Segal M, Johansen K. Predialysis fluid overload and gait speed: a repeated measures analysis among patients on chronic dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2019. PMID: 31886859


  7. Carlos CA, Hsu RK. AKI with Immune Checkpoint Inhibitors: A Push beyond Case Reports. Clinical journal of the American Society of Nephrology : CJASN 2019. PMID: 31672795


  8. Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL. Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely? Journal of the American Society of Nephrology : JASN 2017. PMID: 28336719